Bruce Ribner MD/MPH
- Department of Medicine
Professor Emeritus
- (404) 727-1580
- bribner@emory.edu
-
Health Sciences Research Building
Division of Infectious Diseases
1760 Haygood Drive NE, Suite W319
Overview
Dr. Ribner held faculty positions between 1983-2000, at the University of Texas Health Science Center at Houston Medical School, at Duke University Medical School and the Medical University of South Carolina, Charleston.
Dr. Ribner joined the Emory University School of Medicine in 2000 as the Epidemiologist for the Emory University Hospital, and assistant director of the Occupational Injury Department of Emory Healthcare.
Research and Service
Bruce S Ribner, MD, M.P.H., is a Professor of Medicine in Infectious Diseases at the Emory University School of Medicine, and Medical Director of the Emory University Hospital Serious Communicable Diseases Unit. He is one of the Epidemiologists for Emory University Hospital and the Emory Clinic.
As Medical Director of the Serious Communicable Diseases Unit at Emory University Hospital, he is responsible for overall functioning of the Unit and the care of patients treated for Ebola virus disease and other special pathogens. He is also one of the clinicians who provides direct patient care for the Unit.
Dr. Ribner is the principal investigator for the ASPR contract that established Emory University Hospital as the regional Ebola and other special pathogen treatment center for federal region 4. He is the Principal Investigator for a contract with ASPR and CDC for the consortium of Emory University, the University of Nebraska Medical Center, and the New York Health and Hospitals Corporation, establishing the National Ebola Training and Education Center (NETEC).
Dr. Ribner is a member of the Working Group of the Scientific Interactions Subcommittee of the National Interagency Biodefense Campus and a member of the Working group on guidance for clinical management of filovirus and arenavirus hemorrhagic fevers for the National Institute for Allergy and Infectious Diseases. He also serves on the Occupational Exposure on Call Consult Committee for the Intramural Clinical Management & Operations Branch (ICMOB) of the Division of Clinical Research, National Institute for Allergy and Infectious Diseases.
Previously, he has served as PI or Co-PI on more than 20 federal or non-federal research projects.
He is the author of more than 64 peer review publications in outstanding journals including The New England Journal of Medicine, Clinical Microbiology, Infection Control Hospital Epidemiology, and Annuals of Internal Medicine. He has written 15 book chapters, and 1 set of guidelines. He has received numerous honors and recognitions.
His service, dedication, and contributions to infection control and hospital epidemiology at Emory have been and continue to be significant; as evidenced by the American Nursing Association when they voted Emory Healthcare as one of the 3 best programs in the United States.
Dr. Ribner was voted as one of 4 best infectious disease physicians in Atlanta by other physicians in 2005, 2007, and 2009 through 2017.
Teaching
Dr. Ribner serves as a teacher, role model and mentor to medical students, residents, and fellows. He has taught medical students classes from 1991 to the present and been very active in graduate programs. He currently lectures Infectious Diseases fellows, residents for the noon Internal Medicine series, the Rollins School of Public Health in hospital epidemiology, and the nurse anesthetist training program. He supervises fellows, medical residents and medical students on the Infectious Diseases Consult service at the Emory University Hospital, and the Emory Clinic.
Interests
*Hospital epidemiology
*Prevention and management of serious communicable diseases
Academic Appointment
- Master Clinician, Emory University School of Medicine
- Professor of Medicine, Division of Infectious Diseases, Emory University, School of Medicine
Education
Degrees
- MPH from University of Michigan
- MD from Harvard Medical School
- A.B. from Princeton University
Research
Focus
- My research focus has been in two major areas. The first of these has been the defining of risk factors, designing of interventions for prevention, and evaluating newer agents for the treatment of resistant, hospital acquired, organisms.
Publications
-
Approach to Cataract Surgery in an Ebola Virus Disease Survivor with Prior Ocular Viral Persistence.
Emerg Infect Dis Volume: 26 Page(s): 1553 - 1556
07/01/2020 Authors: Wells JR; Crozier I; Kraft CS; Sexton ME; Hill CE; Ribner BS; Bavari S; Palacios G; Pearce WA; Van Gelder R -
Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States.
Infect Control Hosp Epidemiol Volume: 41 Page(s): 385 - 390
04/01/2020 Authors: Kraft CS; Mehta AK; Varkey JB; Lyon GM; Vanairsdale S; Bell S; Burd EM; Sexton ME; Cassidy LA; Olinger P -
New filovirus disease classification and nomenclature.
Nat Rev Microbiol Volume: 17 Page(s): 261 - 263
05/01/2019 Authors: Kuhn JH; Adachi T; Adhikari NKJ; Arribas JR; Bah IE; Bausch DG; Bhadelia N; Borchert M; Brantster AB; Brett-Major DM -
Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.
Emerg Infect Dis Volume: 25 Page(s): 290 - 298
02/01/2019 Authors: McElroy AK; Shrivastava-Ranjan P; Harmon JR; Martines RB; Silva-Flannery L; Flietstra TD; Kraft CS; Mehta AK; Lyon GM; Varkey JB -
Activated macrophages as pathogenesis factors in Ebola virus disease in humans
Volume: 200
05/01/2018 Authors: McElroy AK; Shrivastava-Ranjan P; Harmon JR; Martines R; Silva-Flannery L; Flietstra TD; Kraft CS; Mehta AK; Lyon GM; Varkey J -
New Lineage of Lassa Virus, Togo, 2016.
Emerg Infect Dis Volume: 24 Page(s): 599 - 602
03/01/2018 Authors: Whitmer SLM; Strecker T; Cadar D; Dienes H-P; Faber K; Patel K; Brown SM; Davis WG; Klena JD; Rollin PE -
Ebola Infection in Pregnancy: A Global Perspective and Lessons Learned.
Clin Obstet Gynecol Volume: 61 Page(s): 186 - 196
03/01/2018 Authors: Haddad LB; Horton J; Ribner BS; Jamieson DJ -
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
Clin Infect Dis Volume: 65 Page(s): 855 - 859
09/01/2017 Authors: Raabe VN; Kann G; Ribner BS; Morales A; Varkey JB; Mehta AK; Lyon GM; Vanairsdale S; Faber K; Becker S -
A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
J Infect Dis Volume: 215 Page(s): 1862 - 1872
06/15/2017 Authors: McElroy AK; Akondy RS; Harmon JR; Ellebedy AH; Cannon D; Klena JD; Sidney J; Sette A; Mehta AK; Kraft CS -
The National Ebola Training and Education Center: Preparing the United States for Ebola and Other Special Pathogens.
Health Secur Volume: 15 Page(s): 253 - 260
01/01/2017 Authors: Kratochvil CJ; Evans L; Ribner BS; Lowe JJ; Harvey MC; Hunt RC; Tumpey AJ; Fagan RP; Schwedhelm MM; Bell S